Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)

Apabetalone (RVX-208) is an epigenetic regulator developed to treat cardiovascular disease (CVD) that targets BET proteins. Through transcriptional regulation RVX-208 modulates pathways that underlie CVD including reverse cholesterol transport, vascular inflammation, coagulation, and complement. Usi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cardiovasc Transl Res
Hoofdauteurs: Wasiak, Sylwia, Gilham, Dean, Tsujikawa, Laura M., Halliday, Christopher, Calosing, Cyrus, Jahagirdar, Ravi, Johansson, Jan, Sweeney, Michael, Wong, Norman C., Kulikowski, Ewelina
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5585290/
https://ncbi.nlm.nih.gov/pubmed/28567671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-017-9755-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items